Breakthrough T1D Australia

Join us on Tuesday 27 October, 6.30pm-8.30pm AEDT, for a free online summit on adjunctive therapies in type 1 diabetes (T1D). Sessions cover GLP-1 and dual GLP-1/GIP receptor agonists, SGLT2 inhibitors and managing ketoacidosis risk, the diabetes educator's role, and a lived experience perspective, followed by a Q&A. This is an ADEA Endorsed Program (2 CPD points). Register now to join live or access the recording.

Our next free summit for healthcare professionals will be held on Tuesday 27 October, 6.30pm-8.30pm AEDT, covering adjunctive therapies in type 1 diabetes (T1D). Leading clinicians will discuss T1D and GLP-1 and dual GLP-1/GIP receptor agonists and SGLT inhibitors, as well as current Australian trials and referral pathways. This ADEA Endorsed Program is free to attend - register now.

Diabetes educators, endocrinologists and other healthcare professionals are invited to a free online summit on adjunctive therapies in type 1 diabetes (T1D) on Tuesday 27 October, 6.30pm-8.30pm AEDT. In this ADEA Endorsed Program, you'll: ✔ get practical guidance on prescribing GLP-1 and dual GLP-1/GIP receptor agonists and SGLT inhibitors in T1D ✔ hear the latest on Australian clinical trials, patient access and referral pathways ✔ learn from people with lived experience about why they use adjunctive therapies Can't make it live? Register to access the recording.

How do GLP-1 receptor agonists, tirzepatide and SGLT2 inhibitors fit into type 1 diabetes (T1D) care? Join our free online summit for healthcare professionals on Tuesday 27 October, 6.30pm-8.30pm AEDT. This ADEA Endorsed Program will cover consensus guidelines, current Australian trials, patient access and referral pathways, plus the lived experience perspective. Register now!

"People don't buy what we do, they buy why we do it" For those who know me well, you'll know I love Simon Sinek's The Optimism Company. Not only for his dulcet tones and charming curiosity on his "A Bit of Optimism" podcast. Also, for his understanding of people's innate desire to belong and connect. Since joining Breakthrough T1D in July, I've seen firsthand how our community shows up for our mission, and how they are deeply connected to our vision for a world without type 1 diabetes (T1D). I've seen family members mobilise, workplace groups muster and neighbourhood teams rally to bring a collective energy and commitment to what we do: fundraise to accelerate research into finding a cure and improving treatments for those living with T1D, like my son Ben. To you, I say thank you for buying into why we do it. And Simon, if you'd like to see how this translates for us on the ground, join us for One Ride. 20-22 November in the beautiful Barossa Valley. We're riding together for something that matters. https://lnkd.in/gU2f7nGx

I’m taking on the Breakthrough T1D One Ride! 🚴♂️ On 21 November 2026, I’ll be jumping on the bike and cycling 80k’s through the picturesque Barossa Valley to raise vital funds for type 1 diabetes research. Now, cardio and I don’t exactly get along… 😂 So I can confidently say this will push me well and truly outside my comfort zone! But it’s all for a powerful cause, and I’m excited to take on the challenge. Type 1 diabetes can affect anyone, at any time. Every day, 8 Australians are diagnosed. It’s a relentless 24/7 condition, requiring up to 180 extra decisions every single day just to stay safe and healthy. Breakthrough T1D is the largest funder of type 1 diabetes research in the world, driving life-changing breakthroughs for the 140,000+ Australians living with T1D. Every donation, no matter how big or small, helps fund research, support innovation and bring us one step closer to a world without type 1 diabetes. 💙 Please consider donating today and supporting me on this challenge. Thank you so much for your support, it genuinely means a lot! TO DONATE: https://lnkd.in/eUU5agVK LINK IS ALSO IN MY BIO 🔗